English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMany adolescents and young women gain weight in the years after breast reduction surgery – particularly those who were at a healthy body mass index (BMI) before surgery, reports a paper in the February issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Tag: Obesity
Guided Self-Help Makes Treating Children With Obesity Easier and More Affordable
According to a new study from researchers at the University of California San Diego’s Center for Healthy Eating and Activity Research (CHEAR), self-guided family therapy for obesity could work just as well as traditional approaches at a fraction of the cost.
Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients with Cirrhosis and Obesity
A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone. The results were published in Nature Medicine journal.
Myth busted: Healthy habits take longer than 21 days to set in
We’re nearly one month into 2025, but if you’re struggling to hold onto your New Year’s resolution, stay strong, as University of South Australia research shows that forming a healthy habit can take longer than you expect.
What’s Next for Weight Loss in 2025? Some Say It’s Time to Say Goodbye to the BMI, Among Other Things…
This National Healthy Weight Week, there’s a growing call to overhaul the way obesity is currently diagnosed.
At Least 60% of Americans To Have Heart Disease By 2050, According To Alarming Study – Cardiology Experts Offer Tips To Know This Heart Month
One in 5 deaths each year are a result of Heart Disease, and the American Heart Associations anticipates the problem to get worse in the next 25 years. An AHA report says the surge of cardiovascular risk factors, such as…
Gene Expression Differences in Fat Tissue May Inform Targeted Treatment for Obesity
New research reveals significant differences in gene expression related to metabolism, inflammation and cardioprotection in the fat tissue of lean and obese mice. These findings could advance the development of targeted therapies for different types of adipose tissue, addressing critical health concerns.
‘Weather’ it’s hot, or not: Aussies overindulge at Christmas
In the first study of its kind, University of South Australia researchers found that compared to the yearly average, people’s alcohol intake in December was 70% higher, non-alcoholic drinks (like juice and soft drinks) were about 30% higher, and sweet and savoury snacks were about 10% higher.
Ultraprocessed Foods Account for More than Half of Calories Consumed at Home
A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health found that more than half of calories consumed at home by adults in the U.S. come from ultraprocessed foods.
Researchers Discover New Neurons that Suppress Food Intake
In a study published in the Dec. 5 issue of Nature, a team of researchers discovered a new population of neurons that is responsive to the hormone leptin. Leptin responsive neurons are important in obesity since leptin is sent to the brain from the body’s fat stores to suppress hunger.
Truck drivers need tailored health supports to Keep on Truckin’
It might seem out of place on the side of a highway, but purpose-built exercise equipment installed at truck stops across Australia could be just the thing to encourage truck drivers to take a break and take control of their health and wellbeing.
Breakthrough obesity treatment: a micro cure for a big problem
University of South Australia researchers have created a new, food-grade, natural solution for obesity, that not only cuts the kilos and improves metabolic health but does so without the nasty side effects.
Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients
A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.
Can policy stop the obesity epidemic?
UC Irvine & UC Merced develops first-of-its-kind database of California’s obesity-related legislation to advance the evidence base for public health law and inform future policymaking so that impactful and inclusive solutions can be prioritized.
Johns Hopkins School of Nursing Launches Center for Equity in Child and Youth Health and Wellbeing
The Johns Hopkins School of Nursing has established a Center for Equity in Child and Youth Health and Wellbeing.
Vitamin D supplements may lower blood pressure in older people with obesity
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
New Study Finds Obesity Can Be Prevented in Very Young Children
A large study co-led by Kori Flower, MD, MS, MPH, division chief of General Pediatrics and Adolescent Medicine at the UNC School of Medicine demonstrates that combining text messaging with in-person clinic counseling reduces obesity in the first two years of life.
Meal timing may be crucial for night shift workers’ health
A new Australian study published in Diabetologia this week has found that overnight eating may be putting night shift workers at higher risk of chronic health conditions.
Antibody Shows Promise Against Obesity-related Liver Disease and Atherosclerosis in Mice
Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.
Sharon M. Donovan Pediatric Nutrition Seminar Fund launched to advance children’s health
The Division of Nutritional Sciences (DNS), housed within the College of Agricultural, Consumer and Environmental Sciences at the University of Illinois Urbana-Champaign, has established the “Sharon M. Donovan Pediatric Nutrition Seminar Fund.”
Study finds intense exercise may suppress appetite in healthy humans
A vigorous workout does more to suppress hunger levels in healthy adults than does moderate exercise, and females may be especially susceptible to this response, according to a small study published in the Journal of the Endocrine Society.
Can small bursts of activity throughout the day decrease chronic pain?
Setting out to prove that movement indeed is medicine for older adults with chronic knee and hip pain, Wake Forest University researchers have received a $5.7 grant from the National Institutes of Health (NIH) to conduct a five-year study.
Routine blood test can identify laboring women at risk for preeclampsia, prompt interventions to protect mom and baby
A simple blood test could help doctors identify women in labor who are at risk for preeclampsia — a leading cause of maternal death — and take precautions to prevent it, according to research presented at the ANESTHESIOLOGY® 2024 annual meeting.
Bariatric Surgery Is More Cost Effective Than Newer Weight Loss Drugs Alone
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco, California. Further, a second study presented at the meeting found that this increasingly popular class of weight loss drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RA, appears safe and may be a novel approach to treating obesity when used before bariatric surgery.
Experts debate pharmacologic management of a patient with obesity
In a new Annals “Beyond the Guidelines” feature, two internal medicine physicians discuss treatment for a patient with obesity and prediabetes in the context of American Gastroenterological Association (AGA) evidence-based recommendations for the pharmacologic management of obesity in adults.
Medical and Psychological Harms of Obesity Depend on Where You Live, Study Indicates
Researchers led by Jana Berkessel of the University of Mannheim in Germany collected archival data on more than 3.4 million people living in the United States and United Kingdom. They found evidence that obesity tends to spur lighter medical and psychological harms when those who struggle with the disorder feel less conspicuous.
$5M Grant Launches Six-State Research Initiative to Reduce Childhood Obesity
In the past four decades, the rate of childhood obesity has quadrupled, increasing kids’ risk of serious conditions. A new research center based at University of Utah Health aims to reduce childhood obesity throughout the Mountain West, focusing on rural and small-town communities.
Alarming Surge: Global Crisis of Childhood Overweight and Obesity
Since 1990, childhood obesity has nearly doubled globally, with the U.S. at the forefront. In Southern Europe, 10-15% of children are obese, while Asia has nearly half of all overweight kids under 5. Nearly 70% of the average U.S. child’s diet consists of ultra-processed foods, which are increasingly consumed by children under 24 months, raising obesity risks and reducing immunological protection. Addressing pediatric obesity requires a multifaceted approach from tackling the influence of social media and advertising on children’s food choices to increasing physical activity.
Obesity in mums doubles the risk of autism in babies
Children born to mothers with obesity both before and during pregnancy have an increased risk of neuropsychiatric and behavioural conditions, including autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD), according to new research from the University of South Australia.
Proteins prohibitins can become new targets for drugs from obesity
Scientists from Immanuel Kant Baltic Federal University analyzed scientific works dedicated to the role of proteins prohibitins in the development of obesity. It turned out that these proteins promote development of inflammation both in separate cells and the whole organism. This happens because prohibitins stimulate emission of anti-inflammatory substances by immune cells, and also participate in destruction of mitochondria damaged during oxidative stress. Obtained information points to the fact that prohibitins can become targets for medicine aimed at struggle with obesity consequences. Results of the research are published in the magazine Frontiers in Molecular Biosciences.
American Society of Nephrology Releases Kidney Health Guidance on the Management of Obesity in Persons with Kidney Diseases
To promote high-quality, person-directed care across the spectrum of kidney health and diseases the American Society of Nephrology (ASN) is releasing its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons Living with Kidney Diseases in the Journal of the American Society of Nephrology (JASN) on September 18, 2024.
Obesity Management and Kidney Health: Live Expert Panel
Reporters are invited to this live event on Obesity Management and Kidney Health. Experts from the American Society of Nephrology will take questions on the inaugural Kidney Health Guidance on managing obesity in kidney disease patients
Endurance Exercise without Weight Loss May Reduce Body Fat
Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.
Girls may start puberty early due to chemical exposure
Girls exposed to certain endocrine-disrupting chemicals (EDCs) may be more likely to start puberty early, according to new research published in Endocrinology, the flagship basic science journal of the Endocrine Society. EDCs mimic, block or interfere with hormones in the body’s endocrine system.
Pregnant women exposed to PFAS may be at risk for obesity, heart disease later in life
Women with higher levels of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems later in life, according to new research published in The Journal of Clinical Endocrinology & Metabolism.
Breaking the link between obesity and atrial fibrillation with a new cellular target
Blocking oxidative stress enzyme prevents, even reverses, heart condition in lab models
First Patient Dosed in Phase 2 Clinical Study of Palatin’s Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that patient dosing has started for the clinical study entitled: BMT-801: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Study Investigating the Safety, Tolerability, and Effectiveness of the Co-Administration of Bremelanotide with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity (ClinicalTrials.gov Identifier: NCT06565611).
Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control
New research finds a combination of drugs improves weight loss, glucose control and insulin resistance better than either drug alone. Using two diabetes medications together, such as a semaglutide like Ozempic or Rybelsus, with a second, newer class of drug, may offer a noninvasive solution to help people with Type 2 diabetes lose weight and manage their condition without the need for bariatric surgery.
Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research
Rohit N. Kulkarni, MD, PhD, the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at Joslin Diabetes Center, has been awarded $9,920,607 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Brain Electrical Stimulation Suppresses Appetite. A New Frontier in Obesity Treatment?
The team led by Dr. Shin of KERI has proposed a novel approach which is to suppress appetite by stimulating cerebral cortex electrically through scalp.
The Medical Minute: The truth about diabetes
Type 1? Type 2? Do you have to take injections for the rest of your life? A Penn State Health expert discusses diabetes and how there are more options than ever to beat it.
Navigating a weight loss journey
One patient details her success story losing weight through this individualized approach
Study Uncovers Connections Between Obesity and Heart Failure
A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a form of heart failure called heart failure with a preserved ejection fraction (HFpEF).
Uncontrolled Hypertension: The Old ‘Silent Killer’ is Alive and Well
High blood pressure affects about 45% of U.S. adults. In the 1970s, only about 50% of patients were aware of their hypertension. Today, 54% are aware of their high blood pressure, 40% are actively treated and 21% are actively controlled. As such, researchers alert health care providers that the old “silent killer” is alive and well.
Rutgers Names Nationally Recognized Clinician-Scientist in Obesity and Nonalcoholic Fatty Liver Disease as New Chair of Medicine
Jeanne M. Clark, a board-certified internal medicine physician with extensive research experience and a nationally renowned expert in the epidemiology and treatment of obesity, will join Rutgers Robert Wood Johnson Medical School as the Henry Rutgers Professor and chair of the Department of Medicine.
Semaglutide may show promise for smoking cessation
New use of semaglutide was associated with a lower risk for medical care related to tobacco use disorder (TUD) in smokers with type 2 diabetes compared with 7 other anti-diabetes medications.
New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription
Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.
For clinicians, diagnostic criteria for obesity remains elusive
Obesity now affects 2 in 5 U.S. adults, making it one of the most important public health problems facing society. However, finding an accurate way to identify obesity in individuals remains challenging given the very diverse U.S. patient population.
Data shows surge in in new GLP-1RA prescriptions for obesity without type 2 diabetes
A nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, by far, in 2023.
What fat cats on a diet may tell us about obesity in humans
Pet cats may be excellent animal models for the study of obesity origins and treatment in humans, a new study of feline gut microbes suggests – and both species would likely get healthier in the research process, scientists say.